The abstract is read at the publisher; the summary is JClub's.
RepoV enables single-copy integration of enhancer reporters in human iPS cells, and neural organoid assays show FOXG1 enhancers with activity patterns matching endogenous FOXG1 expression and patient-linked variant phenotypes.
- Why it matters: Conventional transgenesis is confounded by variable copy number and position effects, and model-organism developmental differences limit testing human CREs in human-specific contexts.
- What they did: The RepoV vector uses PhiC31-mediated recombination to insert enhancer reporters as single copies into human iPS cells, then tests candidate neurodevelopmental enhancers in neural organoids.
- The result: RepoV recapitulates activity of known regulatory elements and reveals that two FOXG1 enhancers differ between zebrafish larvae and human organoids, with organoid activity aligning better with endogenous expression and disease-related variant phenotypes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.